Back to School: How biopharma can reboot drug development. Access exclusive analysis here
InSite regained North American development rights to AzaSite Xtra 2% azithromycin ophthalmic solution from Inspire Pharmaceuticals
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury